In newly diagnosed polymyalgia rheumatica, weekly methotrexate improved glucocorticoid-free remission rates at 1 y

Key Points

• This research aims to evaluate the impact of weekly methotrexate on glucocorticoid-free remission rates in patients with newly diagnosed polymyalgia rheumatica.
• Evaluated newly diagnosed patients with polymyalgia rheumatica
• Administered weekly methotrexate
• Tracked remission rates over one year
• Increased glucocorticoid-free remission rates after one year
• Improved management outcomes for polymyalgia rheumatica patients

Abstract